Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 2
2014 1
2015 2
2016 1
2019 1
2020 1
2021 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Myeloproliferative neoplasms.
Publicover A, Medd P. Publicover A, et al. Clin Med (Lond). 2013 Apr;13(2):188-92. doi: 10.7861/clinmedicine.13-2-188. Clin Med (Lond). 2013. PMID: 23681871 Free PMC article.
Donor monocyte-derived macrophages promote human acute graft-versus-host disease.
Jardine L, Cytlak U, Gunawan M, Reynolds G, Green K, Wang XN, Pagan S, Paramitha M, Lamb CA, Long AK, Hurst E, Nair S, Jackson GH, Publicover A, Bigley V, Haniffa M, Simpson AJ, Collin M. Jardine L, et al. Among authors: publicover a. J Clin Invest. 2020 Sep 1;130(9):4574-4586. doi: 10.1172/JCI133909. J Clin Invest. 2020. PMID: 32453711 Free PMC article.
Host versus graft HLA-DP1 mismatching promotes graft versus host disease.
Wright C, Reid G, Lendrem BC, Hurst E, Publicover A, Luke R, Duncan L, Bigley V, Collin M. Wright C, et al. Among authors: publicover a. Bone Marrow Transplant. 2023 Aug;58(8):950-952. doi: 10.1038/s41409-023-02003-6. Epub 2023 May 6. Bone Marrow Transplant. 2023. PMID: 37149672 No abstract available.
Serum Flt3 ligand is a biomarker of progenitor cell mass and prognosis in acute myeloid leukemia.
Milne P, Wilhelm-Benartzi C, Grunwald MR, Bigley V, Dillon R, Freeman SD, Gallagher K, Publicover A, Pagan S, Marr H, Jones GL, Dickinson AM, Grech A, Burnett AK, Russell NH, Levis M, Knapper S, Collin M. Milne P, et al. Among authors: publicover a. Blood Adv. 2019 Oct 22;3(20):3052-3061. doi: 10.1182/bloodadvances.2019000197. Blood Adv. 2019. PMID: 31648336 Free PMC article.
Letermovir prophylaxis in T-cell-depleted transplants: breakthrough and rebound infections in the postmarketing setting.
Marzolini MAV, Mehra V, Thomson KJ, Tholouli E, Bloor AJC, Parker A, Lovell R, Orchard K, Publicover A, Nicholson E, Snowden JA, Byrne J, Khan A, Gilleece MH, Errico G, Lozano S, Hurst E, Duncan N, Pirrie J, Crea P, Carpenter B, Pagliuca A, Peggs KS. Marzolini MAV, et al. Among authors: publicover a. Blood Adv. 2021 Nov 9;5(21):4500-4503. doi: 10.1182/bloodadvances.2021005637. Blood Adv. 2021. PMID: 34614515 Free PMC article. No abstract available.
Application of the pMHC Array to Characterise Tumour Antigen Specific T Cell Populations in Leukaemia Patients at Disease Diagnosis.
Brooks SE, Bonney SA, Lee C, Publicover A, Khan G, Smits EL, Sigurdardottir D, Arno M, Li D, Mills KI, Pulford K, Banham AH, van Tendeloo V, Mufti GJ, Rammensee HG, Elliott TJ, Orchard KH, Guinn BA. Brooks SE, et al. Among authors: publicover a. PLoS One. 2015 Oct 22;10(10):e0140483. doi: 10.1371/journal.pone.0140483. eCollection 2015. PLoS One. 2015. PMID: 26492414 Free PMC article.